Orfadin Capsule
Product Images NDC 66658-120

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Orfadin (NDC 66658-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Swedish Orphan Biovitrum Ab (publ), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Orf01 0015 01

FDA Label Image

Orf01 0015 02

This appears to be a list of components or items related to a syringe or medicine bottle. It includes a black line, barrel and plunger, as well as a ribbed end and an oral syringe. It is unclear what the Adanier refers to, but it may be a brand or model name.*

FDA Label Image

Orf01 0015 03

FDA Label Image

Orf01 0015 04

FDA Label Image

Orf01 0015 05

FDA Label Image

Orf01 0015 06

FDA Label Image

Orf01 0015 07

FDA Label Image

Orf01 0015 08

FDA Label Image

Orf01 0015 09

FDA Label Image

Orf01 0015 10

FDA Label Image

Orf01 0015 11

FDA Label Image

Orf01 0015 12

FDA Label Image

Orf01 0015 13

FDA Label Image

Orf01 0015 14

FDA Label Image

Orf01 0015 15

Orfadin is a drug available in capsule form and contains the active ingredient Nitisinone. It is used orally and should be stored refrigerated at 2°C to 8°C. If kept at room temperature (up to 25°C (77 °F)), it must be used within 45 days. The package insert should be read before use. Orfadin is marketed in the USA by Sobi Inc. and manufactured by Apotek Produktion & Laboratorier AB, Sweden. The NDC code for Orfadin Capsules is 66658-102-60.*

FDA Label Image

Orf01 0015 16

Orfadin is a medication available only by prescription in capsule form with an NDC of 66658-102-60 containing 60 capsules. The medication, with the active ingredient Nitisinone, requires refrigeration and should be stored at a temperature between 2-8°C (36-46°F). This medication is marketed by Sobi, Inc and manufactured by Apotek Produktion & Laboratorier AB in Sweden. Some additional details such as the expiration date and lot number are missing.*

FDA Label Image

Orf01 0015 17

Orfadin® Capsules (Nitisinone) are a medication for oral use, manufactured by Apotek Produktion & Laboratorier AB, Sweden, and marketed by Sobi, Inc. Each package contains 60 capsules of 5mg. It is recommended to keep the medication refrigerated between 2°C to 8°C (36 F t0 46 °F), but it may be kept at room temperature (up to 25 °C (77 °F)) and must be used within 45 days. If not used within 45 days, the unused portion must be discarded. The text also mentions the presence of a package insert and Rx-only status of Orfadin.*

FDA Label Image

Orf01 0015 18

This is a product label for Orfadin® capsules. It contains information about the manufacturer, dosage, storage, and expiration date of the drug. It is intended for oral use only and requires a prescription. The capsules contain Nitisinone and come in a package of 60. The medication should be refrigerated and stored at a temperature of 2-8°C (36-46°F). The product is manufactured by a company named Sobi, Inc. This label provides a lot number and an expiration date.*

FDA Label Image

Orf01 0015 19

Orfadin® Capsules (Nitisinone) is a prescription medication that comes in packs of 60 capsules with each capsule containing 10 mg. The medication is manufactured by Apotek Produktion & Laboratorier AB, Sweden, and marketed by Sobi, Inc. It is recommended to store the medication refrigerated at 2°C to 8°C (36 °F to 46 °F) or at room temperature within 45 days. Orfadin is for oral use only and its package insert should be consulted before use.*

FDA Label Image

Orf01 0015 20

This is a description of a drug called Orfadin, which comes in capsule form and is intended for oral use only. The National Drug Code (NDC) for this drug is 66658-110-60, and it is only available by prescription. The package insert for the drug is included and it is recommended to store the drug in a refrigerated area between 2-8°C (36-46 °F). The drug is manufactured by Sobi, Inc and distributed by Apotek Produktion & Laboratorier AB in Sweden. An expiration date and lot number are also included.*

FDA Label Image

Orf01 0015 21

Orfadin® Capsules (Nitisinone) is a medication that comes in a 60 capsule pack with each capsule containing 20 mg for oral use only. The medication is manufactured by Apotek Produktion & Laboratorier AB in Sweden, and marketed by Sobi, Inc in MA, US. It should be stored refrigerated at 2°C to 8°C (36°Ft0 46 °F) and can be kept at room temperature (up to 25°C (77 °F)) for 45 days, after which unused portions must be discarded. The text in the document appears to be an insert for the medication and also contains usage instructions.*

FDA Label Image

Orf01 0015 22

This is a description for Orfadin® capsules, which are intended for oral use and come in a 60-capsule package that requires a prescription. The medication should be stored refrigerated at 2-8°C (36-46 °F). It contains 20mg of nitisinone and is marketed by Sobi, Inc. The manufacturer is Apotek Produktion & Laboratorier AB, with an address in Sweden. The text also includes lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.